New study tests Long-Term skin relief for psoriasis patients
Disease control
Not yet recruiting
This study aims to see how well and how safely the drug apremilast works for adults with moderate-to-severe psoriasis over 32 weeks. About 425 participants will take the drug and have their skin symptoms and quality of life checked at regular visits. The goal is to gather more re…
Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC